Ryzodeg® (insulin degludec/insulin aspart) approved in Japan (25 December 2012)

[at noodls] – Bagsværd, Denmark, 25 December 2012 – Novo Nordisk today announced that the Japanese Ministry of Health, Labour and Welfare has approved Ryzodeg® (insulin degludec/insulin aspart) for the treatment of … more

View todays social media effects on NVO

View the latest stocks trending across Twitter. Click to view dashboard

See who Novo is hiring next, click here to view